XML 38 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measures
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measures
Fair Value Measures
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. U.S. GAAP guidance defines three levels of inputs that may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset and liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.
Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.
The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the three months ended March 31, 2018. The Company expects that changes in classifications between levels will be infrequent.
Items Measured at Fair Value on a Recurring Basis
The following tables present information about the Company’s assets and liabilities measured at fair value on a recurring basis as of March 31, 2018 and December 31, 2017, aggregated by the level in the fair value hierarchy within which those instruments fall (in thousands):


Level 1

Level 2

Level 3

Balance as of March 31, 2018
Assets:








CMBS
 
$

 
$

 
$
35,741

 
$
35,741

Derivative assets


 
848

 


848

Investment in Cole REITs
 

 

 
7,844

 
7,844

Total assets
 
$

 
$
848

 
$
43,585

 
$
44,433




Level 1

Level 2

Level 3

Balance as of December 31, 2017
Assets:
 
 
 
 
 
 
 
 
CMBS
 
$

 
$

 
$
40,974

 
$
40,974

Derivative assets
 

 
627

 

 
627

Total assets
 
$

 
$
627

 
$
40,974

 
$
41,601


CMBS – The Company’s CMBS are carried at fair value and are valued using Level 3 inputs. The Company used estimated non-binding quoted market prices from the trading desks of financial institutions that are dealers in such securities for similar CMBS tranches that actively participate in the CMBS market. Broker quotes are only indicative of fair value and may not necessarily represent what the Company would receive in an actual trade for the applicable instrument. Management determines that the prices are representative of fair value through its knowledge and experience in the market. The significant unobservable input used in valuing the CMBS is the discount rate or market yield used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. Significant increases or decreases in the discount rate or market yield would result in a decrease or increase in the fair value measurement. The following risks are included in the consideration and selection of discount rates or market yields: risk of default, rating of the investment and comparable company investments.
Derivative Assets and Liabilities The Company’s derivative financial instruments relate to interest rate swaps, discussed in Note 10 – Derivatives and Hedging Activities. The valuation of derivative instruments is determined using a discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, as well as observable market-based inputs, including interest rate curves and implied volatilities. In addition, credit valuation adjustments are incorporated into the fair values to account for the Company’s potential nonperformance risk and the performance risk of the counterparties.
Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with those derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. However, as of March 31, 2018, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of the Company’s derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.
Investment in Cole REITs As discussed in Note 2 – Summary of Significant Accounting Policies, subsequent to the sale of Cole Capital and adoption of ASU 2016-01, the Company carried its investment in the Cole REITs at fair value, as the Company does not exert significant influence over CCIT II, CCIT III or CCPT V. The fair values of these investments have been estimated using the net asset value per share of CCIT II and CCPT V. The Company determined that the CCIT III per share primary offering price net of selling commissions and dealer manager fees approximated fair value. Each of the Cole REIT’s share redemption programs includes restrictions that limit the number of shares redeemed by the respective Cole REIT. Beginning in 2017, CCIT II and CCPT V limited the amount of shares redeemed and CCIT III has had no share redemptions. CCIT II has estimated that it will commence a liquidity event over the next three to five years. CCPT V has estimated that it will commence a liquidity event over the next three to six years following the termination of its initial public offering. CCIT III has estimated that it will commence a liquidity event five to seven years following the termination of its initial public offering.
The fair value of short-term financial instruments such as cash and cash equivalents, restricted cash, due to affiliates and accounts payable approximate their carrying value in the accompanying consolidated balance sheets due to their short-term nature and are classified as Level 1 under the fair value hierarchy.
The following are reconciliations of the changes in assets and liabilities with Level 3 inputs in the fair value hierarchy for the three months ended March 31, 2018 and 2017 (in thousands):
 
 
CMBS
 
Investment in Cole REITs (1)
Balance as of December 31, 2017
 
$
40,974

 
$
3,264

Total gains and losses
 
 
 
 
Unrealized loss included in other comprehensive income, net
 
(837
)
 

Realized loss included in other income, net
 
(34
)
 

Unrealized gain included in other income, net
 

 
5,102

Purchases, issuance, settlements
 
 
 
 
Return of principal received
 
(4,402
)
 

Amortization included in net income, net
 
40

 

Sale of investments
 

 
(522
)
Ending Balance, March 31, 2018
 
$
35,741

 
$
7,844

____________________________________
(1)
As discussed in Note 2 – Summary of Significant Accounting Policies , as of December 31, 2017, the Company accounted for its investment in Cole REITs using the equity method of accounting. Subsequent to the sale of Cole Capital, the Company retained interests in CCIT II, CCIT III and CCPT V, which were carried at fair value as of March 31, 2018.

 
 
CMBS
Balance as of December 31, 2016
 
$
47,215

Total gains and losses
 
 
Unrealized loss included in other comprehensive income, net
 
(194
)
Purchases, issuance, settlements
 
 
Return of principal received
 
(3,469
)
Amortization included in net income, net
 
(922
)
Ending Balance, March 31, 2017
 
$
42,630


The fair values of the Company’s financial instruments that are not reported at fair value in the consolidated balance sheets are reported below (dollar amounts in thousands):
 
 
Level
 
Carrying Amount at March 31, 2018
 
Fair Value at March 31, 2018
 
Carrying Amount at December 31, 2017
 
Fair Value at December 31, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
Mortgage notes receivable
 
3
 
$
20,072

 
$
24,151

 
$
20,294

 
$
28,272

 
 
 
 
 
 
 
 
 
 
 
Liabilities (1):
 
 
 
 
 
 
 
 
 
 
Mortgage notes payable and other debt, net
 
2
 
$
2,090,984

 
$
2,117,893

 
$
2,095,690

 
$
2,144,522

Corporate bonds, net
 
2
 
2,848,944

 
2,834,468

 
2,848,768

 
2,922,027

Convertible debt, net
 
2
 
993,535

 
1,004,406

 
992,218

 
1,012,349

Credit facility
 
2
 
120,000

 
120,000

 
185,000

 
185,000

Total liabilities
 
 
 
$
6,053,463

 
$
6,076,767

 
$
6,121,676

 
$
6,263,898


_______________________________________________
(1)
Current and prior period liabilities’ carrying and fair values exclude net deferred financing costs.

Items Measured at Fair Value on a Non-Recurring Basis
Certain financial and nonfinancial assets and liabilities are measured at fair value on a nonrecurring basis and are subject to fair value adjustments in certain circumstances, such as when there is evidence of impairment.
Real Estate Investments
As discussed in Note 3 – Real Estate Investments and Related Intangibles, during the three months ended March 31, 2018, net real estate assets representing 12 properties were deemed to be impaired and their carrying values totaling $14.2 million were reduced to their estimated fair value of $8.2 million, resulting in impairment charges of $6.0 million. During the three months ended March 31, 2017, net real estate assets related to 14 properties with carrying values totaling $16.6 million were deemed to be impaired and their carrying values were reduced to their estimated fair values of $9.9 million resulting in impairment charges of $6.7 million. The Company estimates fair values using Level 3 inputs and using a combined income and market approach, specifically using discounted cash flow analysis and recent comparable sales transactions. The evaluation of real estate assets for potential impairment requires the Company’s management to exercise significant judgment and to make certain key assumptions, including, but not limited to, the following: (1) capitalization rate; (2) discount rates; (3) number of years property will be held; (4) property operating expenses; and (5) re-leasing assumptions including number of months to re-lease, market rental income and required tenant improvements. There are inherent uncertainties in making these estimates such as market conditions and performance and sustainability of the Company’s tenants. For the Company’s impairment tests for the real estate assets during the three months ended March 31, 2018, the Company used a range of discount rates from 7.4% to 7.5% with a weighted-average rate of 7.5% and a capitalization rate of 7.7%.
The following table presents the impairment charges by asset class recorded during the three months ended March 31, 2018 and 2017 (dollar amounts in thousands):
 
 
Three Months Ended March 31,
 
 
2018
 
2017
Properties impaired
 
12

 
14

 
 
 
 
 
Asset classes impaired:
 
 
 
 
Investment in real estate assets, net
 
$
6,043

 
$
6,748

Below-market lease liabilities, net
 
(7
)
 
(23
)
Total impairment loss
 
$
6,036

 
$
6,725